Bio & Pharma
LabGenomics unites with Humanscape on Asia, US genetic testing biz
The two companies agreed to combine overseas businesses in Singapore and Vietnam that had been operated separately
By Dec 20, 2022 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


KT&G eyes overseas M&A after rejecting activist fund's offer


StockX in merger talks with Naver’s online reseller Kream


Mirae Asset to be named Korea Post’s core real estate fund operator



LabGenomics Co., a molecular diagnostics company, said on Tuesday that it has signed an agreement with digital healthcare company Humanscape to develop a direct-to-consumer genetic testing business in Southeast Asia and the United States.
Humanscape runs Mamitalk, a pregnancy and parenting platform with 600,000 subscribers.
The two companies decided to jointly target overseas markets by utilizing prenatal and postnatal genetic testing services for mothers and babies and the Mamitalk platform's capabilities.
The two parties decided to combine overseas businesses that had been carried out separately in Singapore and Vietnam onto a single platform, establish shared facilities, and make advance preparations with local hospitals.
"It is true there were difficulties in identifying new services and distribution channels while operating prenatal and postpartum exam services overseas. We expect to achieve excellent results in the overseas market soon through cooperation with Humanscape," said a LabGenomics official.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
-
Korean startupsData startup BankSalad begins monetizing free genetic testing
Nov 17, 2022 (Gmt+09:00)
1 Min read -
Bio & PharmaPet health: Korean genetic testing firms' new target market
Jun 20, 2022 (Gmt+09:00)
2 Min read
Comment 0
LOG IN